热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Alexa Fluor® 700 anti-human CD45 Antibody
产品名称：
Alexa Fluor® 700 anti-human CD45 Antibody
产品类别：
抗体
产品编号：
304023
产品应用：
304023
[价格]
规格 价格 库存
25µg ￥ 1488 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections and formalin-fixed paraffin-embedded tissue sections9, inhibition of CD45 functions4, immunofluorescence11,?Western blotting3, and spatial biology (IBEX)16,17.

It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Kishihara K, et al. 1993. Cell 74:143.
  3. Esser M, et al. 2001. J. Virol. 75:6173. (WB)
  4. Yamada T, et al. 2002. J. Biol. Chem. 277:28830.
  5. Nagano M, et al. 2007. Blood 110:151.
  6. Jiang Q, et al. 2008. Blood 112:2858. PubMed
  7. Morozov A, et al. 2010. Clin Cancer Res. 16:5630. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Friedman T, et al. 1999. J. Immunol. 162:5256. (IHC)
  10. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed
  11. Rees LE, et al. 2003. Clin. Exp. Immunol. 134:497. (IF)
  12. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
  13. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
  14. Marquardt N, et al. 2015. J Immunol. 6:2467. PubMed
  15. Bushway ME, et al. 2014. Biol Reprod. 90(5): 110. (IF) PubMed
  16. Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
  17. Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
Product Citations
  1. Ivarsson M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.50. PubMed
  2. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  3. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  4. Klemm F, et al. 2020. Cell. 181(7):1643-1660.e17. PubMed
  5. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  6. Bessy T, et al. 2021. J Cell Biol. 220:. PubMed
  7. Wu Y, et al. 2013. J Biosci Bioeng. 64:169. PubMed
  8. Nilsson A, et al. 2016. PLoS One. 11: 0158369. PubMed
  9. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  10. Bj?rklund &, et al. 2016. Nat Immunol. 17:451-460. PubMed
  11. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  12. Zheng S, et al. 2018. Mol Syst Biol. 14:e8041. PubMed
  13. Marquardt N, et al. 2019. Nat Commun. 10:3841. PubMed
  14. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  15. B?iers C, et al. 2018. Dev Cell. 44:362. PubMed
  16. Li L, et al. 2020. J Transl Med. 18:363. PubMed
  17. Kinchen J et al. 2018. Cell. 175(2):372-386 . PubMed
  18. Cassetta L et al. 2019. Cancer Cell. 35(4):588-602 . PubMed
  19. Fedyk ER, et al. 2020. British Journal of Clinical Pharmacology. 86(7):1314-1325.. PubMed
  20. Maas RJ, et al. 2020. Oncoimmunology. 9:1843247. PubMed
  21. Marquardt N, et al. 2016. J Immunol. 197: 3069 - 3075. PubMed
  22. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  23. Alhaj Hussen K, et al. 2017. Immunity. 47:680. PubMed
  24. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  25. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  26. Neal JT, et al. 2018. Cell. 175:1972. PubMed
  27. Butch ER, et al. 2020. Cancer Research. 79(12):3112-3124.. PubMed
  28. Khatamzas E, et al. 2022. Nat Commun. 13:5586. PubMed
  29. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  30. Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed
  31. Shen Z, et al. 2022. Immun Ageing. 19:55. PubMed
  32. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  33. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  34. Hernndez DC, et al. 2021. Immunity. :. PubMed
  35. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
  36. Strand K, et al. 2022. Front Endocrinol (Lausanne). 13:856530. PubMed
  37. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
  38. Bal S, et al. 2016. Nat Immunol. 10.1038/ni.3444. PubMed
  39. Cartellieri M, et al. 2016. Blood Cancer J. 6:e458. PubMed
  40. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  41. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  42. Sun K, et al. 2022. Nat Commun. 13:4943. PubMed
  43. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  44. Marquardt N, et al. 2015. J Immunol. 194:2467. PubMed
  45. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  46. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  47. Williams DW, et al. 2021. Cell. . PubMed
  48. Garfall AL, et al. 2018. JCI Insight. 3. PubMed
  49. Ludwig LS et al. 2019. Cell. 176(6):1325-1339 . PubMed
  50. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  51. Alhaj Hussen K, et al. 2020. Front Immunol. 11:579776. PubMed
  52. Jühling F, et al. 2021. Life Sci Alliance. 4: . PubMed
RRID
AB_493760 (BioLegend Cat. No. 304023) AB_493761 (BioLegend Cat. No. 304024)

Antigen Details

Structure
Tyrosine phosphatases, type I transmembrane protein, 180-240 kD (multiple isoforms)
Distribution

Hematopoietic cells, not expressed in circulating erythrocytes or platelets

Function
TCR and BCR mediated activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
Hematopoietic stem and progenitors, Mesenchymal Stem Cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References
  1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
  2. Trowbridge I, et al. 1994. Annu. Rev. Immunol.12:85.
Gene ID
5788 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线